Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 1.35 · gapped below the open, then crossed back over prior close. High/low 1.39 at 9:30 am ET, 1.31 at 4:00 am ET.
Pacific Biosciences of California, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Laboratory Analytical Instruments
PACB (Pacific Biosciences of California, Inc.) has 1 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
221 institutional managers report a position in Pacific Biosciences of California, Inc. worth $322.7M between them, filed on form 13F for the quarter ending 2026-06-30. 18 of them hold 80% of it, the largest being BlackRock, Inc. at 16.84%.
196 more managers in the register
18 managers hold 80% of the $322.7M institutional base. The other 203 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +1 more · 15.50% of PACB, 15.32% of BLSH
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. · 15.50% of PACB, 17.84% of CNTN
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +1 more · 15.50% of PACB, 13.31% of QSI
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +3 more · 15.50% of PACB, 11.60% of ARCT
via ARK Investment Management LLC, Softbank Group Corp, Sumitomo Mitsui Trust Holdings, Inc. +2 more · 15.50% of PACB, 11.14% of RXRX
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +2 more · 15.50% of PACB, 11.92% of CERS
Managers holding a meaningful stake in PACB also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.